Earnings Ahead

BCLI - Brainstorm Cell Therapeutics Inc.

2.12 -0.03 -1.4

Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.

About

Profile


Headquarters

New York City, New York, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

BCLI



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • BrainStorm Cell Therapeutics Q3 2023 Earnings Preview
  • BrainStorm Cell Therapeutics Q3 2023 Earnings Preview
  • Brainstorm realigns resources to support NurOwn development
  • Brainstorm to pull marketing application for ALS therapy
  • FDA advisory panel votes against BrainStorm ALS therapy
  • BrainStorm stock halted as FDA panel reviews ALS therapy NurOwn
  • Brainstorm falls as FDA posts briefing docs on ALS therapy
  • BrainStorm Cell Therapeutics GAAP EPS of -$0.27 misses by $0.13
  • BrainStorm sells 4.05M shares at $1.85 in registered direct offering
  • BrainStorm announces data from its Phase 3 trial of NurOwn
  • FDA panel to review BrainStorm's NurOwn therapy for ALS
  • Brainstorm Cell COO Setboun to leave company - filing
  • BrainStorm Cell Therapeutics GAAP EPS of -$0.14 beats by $0.03
  • Brainstorm stock pares off gains amid FY22 results seeing cash decline
  • BrainStorm Cell Therapeutics GAAP EPS of -$0.66 misses by $0.52
  • Brainstorm granted FDA AdCom meeting for ALS therapy
  • BrainStorm Cell Therapeutics promotes Stacy Lindborg to co-CEO
  • BrainStorm gets FDA panel meeting to discuss declined filing for ALS drug NurOwn
  • BrainStorm Cell Therapeutics GAAP EPS of -$0.53
  • BrainStorm Cell Therapeutics Q3 2022 Earnings Preview
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
November 15, 2021 -0.15 / -0.24 - / -
August 5, 2021 -0.17 / -0.24 - / -
May 13, 2021 - / -0.25 - / -
April 26, 2021 -0.19 / -0.25 - / -
February 4, 2021 -0.36 / -0.37 - / -
November 11, 2020 - / -0.26 - / 15.37M
October 15, 2020 -0.14 / -0.255 - / -
August 5, 2020 -0.25 / -0.26 - / 15.37M
May 7, 2020 -0.32 / -0.23 - / 15.37M
February 18, 2020 -0.34 / -0.18 750K / 750K
November 14, 2019 -0.25 / -0.17 750K / 750K
October 30, 2019 - / -0.16 - / 750K
August 13, 2019 -0.23 / -0.15 3M / 3M
May 10, 2019 -0.24 / -0.11 750K / 1.5M Beat!
March 29, 2019 -0.27 / -0.14 1.5M / 750K
October 29, 2018 -0.15 / -0.12 750K / 750K
July 23, 2018 -0.16 / -0.13 1.5M / 750K
May 14, 2018 -0.12 / -0.32 - / -
March 28, 2018 - / -0.27 - / -
October 17, 2017 -0.13 / -0.16 - / -
August 16, 2017 -0.06 / -0.16 - / -
May 16, 2017 - / -0.15 - / -
March 30, 2017 -0.04 / -0.3 - / -
November 15, 2016 -0.09 / -0.09 - / -
Date Price Open High Low Vol Change ER
May 13 2.720 2.730
2.792
2.650
99.59K 0.37%
May 12 2.710 2.670
2.787
2.670
86.90K 0%
May 11 2.710 2.770
2.780
2.650
159.20K -2.52%
May 10 2.780 2.790
2.850
2.760
57.96K -1.42%
May 9 2.820 2.990
2.990
2.800
127.99K -7.24%
 
May 6 3.040 3.260
3.260
2.970
162.94K -6.75%
May 5 3.260 2.960
3.330
2.750
253.14K 9.03%
May 4 2.990 2.900
3.092
2.860
123.23K 2.75%
May 3 2.910 2.930
2.940
2.880
40.33K -1.36%
May 2 2.950 2.970
3.040
2.910
39.89K -1.67%
Apr 29 3.000 2.910
3.000
2.910
52.36K 1.69%
Apr 28 2.950 3.100
3.100
2.910
40.86K -1.99%
Apr 27 3.010 3.040
3.040
2.900
64.93K 2.03%
Apr 26 2.950 3.010
3.040
2.910
80.22K -3.59%
Apr 25 3.060 3.080
3.097
3.018
31.88K -0.97%
Apr 22 3.090 3.070
3.100
3.040
16.96K -0.32%
Apr 21 3.100 3.200
3.225
3.050
34.57K 0.98%
Apr 20 3.070 3.200
3.260
3.040
44.41K -3.76%
Apr 19 3.190 3.090
3.240
3.075
33.36K 2.90%
Apr 18 3.100 3.150
3.200
3.080
41.01K -1.59%